Patent · US Active

Methods for vas-occlusive contraception and reversal thereof

US10155063B2 · kind B2 · utility

11Cited by
67References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 11, 2016
Grant dateDec 18, 2018
Priority date
Expiry dateNov 11, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2430/36
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are methods of delivering an agent to the lumen of the vas deferens under guidance of ultrasound imaging. The methods include vas-occlusive contraception in which the vas deferens is non-surgically isolated and an occlusive substance is percutaneously administered into the lumen of the vas deferens under ultrasound. Also disclosed are methods of reversal of vas-occlusive contraception and methods of delivering an agent to the lumen of the vas deferens. Also disclosed are compositions for use in the methods of the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.